Sommacale D, Dondero F, Sauvanet A, Francoz C, Durand F, Farges O, Kianmanesh R, Belghiti J
Department of Hepatopancreatobiliary and Liver Transplantation, Beaujon University-Hospital, APHP, Paris Diderot University (Paris 7), France.
Transplant Proc. 2013 Sep;45(7):2726-8. doi: 10.1016/j.transproceed.2013.07.032.
Liver resection (LR) in liver transplant (OLT) recipients, an extremely rare situation, who performed on 8 recipients.
This retrospective analysis of prospectively collected data concerned 8 (0.66%) 1198 LR cases among OLT performed from 1997 to 2011. We analyzed demographic data, surgical indications, and postoperative courses.
The indications were resectable recurrent hepatocellular carcinomas (HCC, n = 3), persistent fistula from a posterior sectorial duct (n = 1), recurrent cholangitis due to anastomotic stricture on the posterior sectorial duct (n = l), hydatid cyst (n = l), left arterial hepatic thrombosis with secondary ischemic cholangitis (n = 1), and a large symptomatic biliary cyst (n = 1). The mean interval time to liver resection was 23.7 months (range, 5-47). LR included right hepatectomy (n = 1), right posterior hepatectomy (n = 1), left lobectomy (n = 4), pericystectomy (n = 1), or biliary fenestration (n = 1). Which there was no postoperative mortality, the global morbidity rate was 62% (5/8). The mean follow-up after LR was 92 months (range, 11-156). No patients required retransplantation. None of the 3 patients who underwent LR for HCC showed a recurrence.
LR in OLT recipients is safe, but associated with a high morbidity rate. This procedure can avoid retransplantation in highly selected patients, presenting a possible option particularly for transplanted patients with a resectable, recurrent HCC.
肝移植(OLT)受者进行肝切除(LR)极为罕见,本研究中有8例受者接受了该手术。
本研究对1997年至2011年期间进行的1198例OLT手术中的8例(0.66%)LR病例进行了回顾性分析。我们分析了人口统计学数据、手术指征和术后病程。
手术指征包括可切除的复发性肝细胞癌(HCC,n = 3)、肝后段胆管持续瘘(n = 1)、肝后段胆管吻合口狭窄导致的复发性胆管炎(n = 1)、包虫囊肿(n = 1)、左肝动脉血栓形成伴继发性缺血性胆管炎(n = 1)和巨大有症状的胆管囊肿(n = 1)。肝切除的平均间隔时间为23.7个月(范围5 - 47个月)。LR包括右肝切除术(n = 1)、右后肝切除术(n = 1)、左叶切除术(n = 4)、囊肿切除术(n = 1)或胆管开窗术(n = 1)。术后无死亡病例,总体发病率为62%(5/8)。LR后的平均随访时间为92个月(范围11 - 156个月)。无患者需要再次移植。3例因HCC接受LR的患者均未出现复发。
OLT受者进行LR是安全的,但发病率较高。该手术可避免在经过严格筛选的患者中进行再次移植,尤其对于患有可切除复发性HCC的移植患者是一种可能的选择。